Protagonist Therapeutics Inc (PTGX)
30.74
-1.20
(-3.76%)
USD |
NASDAQ |
May 17, 16:00
30.74
0.00 (0.00%)
After-Hours: 20:00
Protagonist Therapeutics Max Drawdown (5Y): 85.79% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 85.79% |
| March 31, 2024 | 85.79% |
| February 29, 2024 | 85.79% |
| January 31, 2024 | 85.79% |
| December 31, 2023 | 85.79% |
| November 30, 2023 | 85.79% |
| October 31, 2023 | 85.79% |
| September 30, 2023 | 85.79% |
| August 31, 2023 | 85.79% |
| July 31, 2023 | 85.79% |
| June 30, 2023 | 85.79% |
| May 31, 2023 | 85.79% |
| April 30, 2023 | 85.79% |
| March 31, 2023 | 85.79% |
| February 28, 2023 | 85.79% |
| January 31, 2023 | 85.79% |
| December 31, 2022 | 85.79% |
| November 30, 2022 | 85.79% |
| October 31, 2022 | 85.79% |
| September 30, 2022 | 85.79% |
| August 31, 2022 | 85.79% |
| July 31, 2022 | 85.79% |
| June 30, 2022 | 85.79% |
| May 31, 2022 | 84.50% |
| April 30, 2022 | 82.13% |
| Date | Value |
|---|---|
| March 31, 2022 | 82.13% |
| February 28, 2022 | 82.13% |
| January 31, 2022 | 82.13% |
| December 31, 2021 | 82.13% |
| November 30, 2021 | 82.13% |
| October 31, 2021 | 82.13% |
| September 30, 2021 | 82.13% |
| August 31, 2021 | 82.13% |
| July 31, 2021 | 82.13% |
| June 30, 2021 | 82.13% |
| May 31, 2021 | 82.13% |
| April 30, 2021 | 82.13% |
| March 31, 2021 | 82.13% |
| February 28, 2021 | 82.13% |
| January 31, 2021 | 82.13% |
| December 31, 2020 | 82.13% |
| November 30, 2020 | 82.13% |
| October 31, 2020 | 82.13% |
| September 30, 2020 | 82.13% |
| August 31, 2020 | 82.13% |
| July 31, 2020 | 82.13% |
| June 30, 2020 | 82.13% |
| May 31, 2020 | 82.13% |
| April 30, 2020 | 82.13% |
| March 31, 2020 | 82.13% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
77.17%
Minimum
May 2019
85.79%
Maximum
Jun 2022
82.99%
Average
82.13%
Median
Dec 2019
Max Drawdown (5Y) Benchmarks
| Lifecore Biomedical Inc | 89.19% |
| SELLAS Life Sciences Group Inc | 100.00% |
| Akebia Therapeutics Inc | 98.40% |
| Immuneering Corp | -- |
| Moderna Inc | 85.65% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -5.869 |
| Beta (5Y) | 2.087 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 100.4% |
| Historical Sharpe Ratio (5Y) | 0.1732 |
| Historical Sortino (5Y) | 0.325 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 30.39% |